Top Banner
Therapeutic Ultrasound Clinical Application
27

Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Mar 26, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Therapeutic Ultrasound

Clinical Application

Page 2: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

FDA Labeling Requirements

• Output frequency• Effective Radiating Area

(ERA)• Beam Nonuniformity Ratio

(BNR)• Beam profile

• Date of last service/ calibration should also be posted on the unit

Page 3: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Treatment Area

• US heats a limited area– About the size of a

catsup packet

• Treatment area should be 2 to 3 times the size of the ERA

• For larger areas, divide the treatment area into smaller zones

Page 4: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Coupling Methods

Direct CouplingImmersion Method

Pad/Bladder Method

Page 5: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Coupling Methods• Ultrasonic energy cannot pass through the

air• A coupling medium is required• Medium should be water-based• Coupling method should confirm to the

body area• The body area should be clean and

relatively hair-free

Page 6: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Direct Coupling

• Gel or Creams• Only use approved

coupling agents• Apply liberally to area• Remove air bubbles by

passing sound head over area (before power is increased)

Page 7: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Direct Coupling• Move the sound

head s-l-o-w-l-y– 4 cm/sec

• Moving the head faster decreases heating

• If the patient describes discomfort, decrease the output intensity

Page 8: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Coupling Ability of Various MediaSubstance Transmission• Saran Wrap 98• Lidex ge, fluocinonide (.05%) 97• Thera-Gesic 97• Mineral oil 97• US Transmission gel 96• US Transmission lotion 90• Chempad-L 68• Hydrocortisone powder (1%) 29• Hydrocortisone powder (10%) 7• Eucerin cream 0• Myoflex 0• White petrolatum gel 0

Page 9: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Immersion Technique• Used to treat irregularly

shaped areas• The limb is immersed in a

tub of degassed water• If tap water is used, increase

the output intensity by 0.5 w/cm2

• Transducer is held appx. 1” from the body part

• Avoid the formation of air bubbles

Page 10: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Pad (Bladder) Method• A mass of

conductive gel– Commercial pads– Self-made bladders

• Conforms to the treatment area

• Commercial pads help limit the size of the treatment area

Page 11: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Output Parameters

Output FrequencyDuration

Duty CycleOutput Intensity

Page 12: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Output Frequency• Determines the treatment depth • 1 MHz Output

– Deep (5 to 7 cm) tissues• Rotator cuff, vastus intermedius, gastroc

• 3 MHz Output– Superficial (up to 3cm deep) tissues

• Patellar tendon, MCL, brachialis

• Remember that adipose tissue is transparent to ultrasound

Page 13: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Treatment Duration• Depends on:

– Size of the treatment area– Output intensity– Therapeutic goals

• Vigorous heating– 1 MHz output

• 10 to 12 minuts

– 3 MHz output• 3 to 4 minutes

• Also see “Output Intensity”

Page 14: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Duty Cycle• Determine the proportion of thermal and

nonthermal effects– High duty cycle: Predominantly thermal effects– Low duty cycle: Predominantly nonthermal effects

• Thermal effect used in subacute and chronic conditions

• Nonthermal effects may be beneficial in acute stages

Page 15: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Output Intensity – 1 MHz

• At a 100% duty cycle

• 1.75 W/cm2 output• Approximately 4 min

treatment is required to increase tissue temp 4°C

Page 16: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Output Intensity – 3 MHz

• At a 100% duty cycle

• 1.5 W/cm2 output• Approximately 10

min treatment is required to increase tissue temp 4°C

Page 17: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Ultrasound and Electrical Stimulation

“Combo Treatment”

Page 18: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

US/Electrical Stimulation• Theoretically combines

the benefit of the two treatments

• Used to treat:– Trigger points– Muscle spasm

• Output parameters:– Thermal ultrasound– Motor level electrical

stimulation

Page 19: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

Set-up and Application

Page 20: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Contraindications• Acute injuries (100% duty

cycle)• Ischemic areas• Areas of impaired circulation

including arterial disease• Over areas of deep vein

thrombosis• Anesthetic areas• Over cancerous tumors • Over sites of active infection or

sepsis• Over the spinal cord or large

nerve plexus in high doses• Exposed metal that penetrates

the skin (e.g., external fixation devices)

• Areas around the eyes, heart, skull, or genitals

• Over the thorax in the presence of an implanted pacemaker

• Pregnancy when used over the pelvic or lumbar areas

• Over a fracture site before healing is complete

• Stress fracture sites or sites of osteoporosis

• Over the pelvic or lumbar area in menstruating female patients

Page 21: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Precautions• Symptoms may increase after the initial

treatments.• Use caution when applying ultrasound around

the spinal cord, especially after laminectomy. • The use of ultrasound over metal implants is not

contraindicated – Keep the sound head moving

• Use caution when applying ultrasound over epiphyseal plates of growing bone

Page 22: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Instrumentation • Duty cycle: Adjusts between continuous and pulsed ultrasound application • Frequency: Selects the depth of penetration• Gel warmer: Used to preheat the transmission gel, primarily for patient

comfort• Intensity: Adjusts the output intensity.

– The WATT METER displays the output in either total watts or watts per square centimeter.

• Maximum head temperature: Prevents overheating in case the head is not properly coupled.

• Pause: Interrupts the treatment but retains the remaining amount of treatment time

• Power: Turns the unit ON or OFF• Start-Stop: Initiates or terminates the production of ultrasound from the

transducer.• Timer: Sets the duration of the treatment. • Watt meter: Displays the output of ultrasound in total watts or watts per

square centimeter.

Page 23: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Patient Preparation • Establish that no contraindications are present• Determine the method and mode of ultrasound application to be

used• Clean the area to be treated• Determine the type of coupling method to be used• Identify a treatment area that is 2 to 3 times the ERA• For direct coupling: spread the gel over the area to be treated• Explain the sensations to be expected during the treatment:

– Mild to moderate warmth (but not pain or burning) for thermal treatments– No subcutaneous sensations during pulsed ultrasound

• For thermal treatments pre-heating with a moist heat pack will decrease the treatment time required to reach vigorous heating levels

• Advise the patient to report any adverse, unusual, or painful sensations during the treatment.

Page 24: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Initiation of the Treatment • Reduce the INTENSITY to zero before turning on the POWER.• Select the appropriate mode for the output (CONTINUOUS or PULSED)• Set the WATT METER to displays the appropriate output for the type of

treatment• Set the TIMER to the appropriate treatment duration• Begin slowly moving the sound head over the medium

– Press the START button to begin the treatment session– Units having low BNR may be moved at a slower rate than those with a higher BNR

• Slowly increase the INTENSITY – Keep the sound head moving

• Move the head at a moderate pace (4 cm per second or slower) • Use firm, yet not strong, overlapping strokes• If pain is experienced:

– Move the sound head at a faster rate– Use a lower duty cycle– Use a lower the intensity

• If the gel begins to wear away or if the sound head begins sticking on the skin, depress the PAUSE button and apply more gel

Page 25: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Phonophoresis Application • Preheating the area to increase the absorption of the

medication• Use only approved ultrasound transmission media.

– The direct coupling method is recommended – Efficacy of phonophoresis using the bladder method has not been

established• Ensure that the skin is well moistened; avoid areas of dry skin• Position the extremity to encourage circulation.• Use a continuous output to maximize the effect of

phonophoresis– Unless the thermal effects of ultrasound are contraindicated

• Follow the procedures described in “Initiation of the Treatment”• After treatment, cover the remaining medication with an

occlusive dressing.

Page 26: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

Termination of the Treatment • If the treatment is being terminated prematurely:

– Reduce the intensity before removing the transducer• Clean the remaining gel from the patient’s skin• To ensure continuity of treatment sessions:

– Record the treatment parameters • Output frequency• Intensity• Duration• Duty cycle• Running count of ultrasound treatments given for this condition

• Immediately initiate any post-treatment stretching

Page 27: Therapeutic Ultrasound Clinical Application. © 2005 – FA Davis FDA Labeling Requirements Output frequency Effective Radiating Area (ERA) Beam Nonuniformity.

© 2005 – FA Davis

MaintenanceDaily Maintenance• Clean ultrasound head and transducer face as

recommended by the manufacturerMonthly Maintenance• Check all electrical cords for frays or kinks• Check the sound head cable for frays or kinks• Clean the transmitter face as recommended by the

manufacturer.

Federal regulations require that therapeutic ultrasound units be recalibrated annually by an authorized service technician